REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 185 filers reported holding REPLIGEN CORP in Q1 2017. The put-call ratio across all filers is 3.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $226,902 | -16.0% | 1,604 | 0.0% | 0.01% | -17.6% |
Q1 2023 | $270,049 | +97743.8% | 1,604 | -1.5% | 0.02% | +13.3% |
Q4 2022 | $276 | -99.9% | 1,629 | 0.0% | 0.02% | -21.1% |
Q3 2022 | $305,000 | +34.4% | 1,629 | +34.7% | 0.02% | +58.3% |
Q1 2022 | $227,000 | -26.5% | 1,209 | +3.6% | 0.01% | +9.1% |
Q4 2021 | $309,000 | -8.3% | 1,167 | 0.0% | 0.01% | -8.3% |
Q3 2021 | $337,000 | -79.0% | 1,167 | -85.9% | 0.01% | -77.4% |
Q1 2021 | $1,608,000 | -28.9% | 8,271 | -29.9% | 0.05% | -40.4% |
Q4 2020 | $2,262,000 | +29.3% | 11,805 | -0.5% | 0.09% | +4.7% |
Q3 2020 | $1,750,000 | +25.3% | 11,864 | +5.0% | 0.08% | +25.0% |
Q2 2020 | $1,397,000 | +23.3% | 11,302 | -3.7% | 0.07% | +6.2% |
Q1 2020 | $1,133,000 | -62.1% | 11,737 | -84.9% | 0.06% | -46.2% |
Q3 2017 | $2,988,000 | -7.8% | 77,969 | -0.3% | 0.12% | -10.5% |
Q2 2017 | $3,240,000 | +11.7% | 78,196 | -5.1% | 0.13% | +9.9% |
Q1 2017 | $2,900,000 | +14.0% | 82,391 | -0.2% | 0.12% | +10.0% |
Q4 2016 | $2,544,000 | – | 82,559 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |